Is 10x Genomics, Inc. (TXG) a Buy, Sell, or Hold?
NASDAQ : TXG
10x Genomics, Inc. — Analyst Ratings
$43.22 USD
-$0.52 (-1.19%)
- Volume
- 2.36M
- Average Volume
- 3.2M
- Market Capitalization
- $5.49B
- P/E Ratio
- -254.24
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $46.32
- Year Low
- $11.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.90
Analyst Consensus Summary
Consensus Rating
Sell
22 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
16.8%
vs Current Price
Price Target
$37.00
Average TargetPrice Target Range
Lowest Target
$17.00
154.2% UPSIDE
Average Target
$37.00
Median Estimate
Highest Target
$50.00
-13.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 22
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 11 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Kyle Mikson | $50 | $41.77 | 2026-07-14 06:55 AM | 19.7% |
| Morgan Stanley | Kallum Titchmarsh | $37 | $37.47 | 2026-07-09 06:56 AM | -1.3% |
| Barclays | Luke Sergott | $40 | $31.87 | 2026-06-24 04:49 AM | 25.5% |
| Stifel Nicolaus | Daniel Arias | $25 | $22.3786 | 2026-03-02 08:18 AM | 11.7% |